Dr. Tania Schink

  • March 2023 - July 2024 Scientific expert im Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency's (EMA)
  • Since 2022 Senior Scientist (Expert)
  • since April 2010 Head of "Drug Safety" unit
  • since February 2009 Research Associate at the Leibniz Institute for Prevention Research and Epidemiology - BIPS
  • June 2007 Doctorate in Medical Sciences, Charité, Humboldt University Berlin
  • November 2007 Master of Public Health, Harvard School of Public Health, Boston, USA; Concentration: Quantitative Methods (Epidemiology & Pharmacoepidemiology), Focus: Decision Sciences
  • March 2001 - February 2008 Research Associate at the Department of Biostatistics and Clinical Epidemiology at the Charité, Universitätsmedizin Berlin
  • January 2000 - December 2000 Research Associate at the Department of Medical Computer Sciences, Biostatistics and Epidemiology at the Ludwig-Maximilians-Universität, München
  • November 1999 Diplom in Statistics, Ludwig-Maximilians-University, Munich

  • Drug and vaccine safety, esp. during pregnancy
  • Use of electronic health record data for pharmacoepidemiologogical research
  • Causal Inference

ORCID logo

Selected BIPS-Publications

  • Articles with peer review

  • Schink T, Braitmaier M, Dathe K, Haug U, Schaefer C, Thöne K, Onken M. Postnatal and long-term outcomes after in utero exposure to RAAS inhibitors: Cohort study based on German claims data. Pediatric Nephrology. 2026;
    https://doi.org/10.1007/s00467-025-07101-9
  • Schink T, Frizler M, Kollhorst B, Haug U. Use of carbimazole, methimazole and propylthiouracil in women of childbearing age and exposed pregnancies in Germany: A population-based study. Drugs - Real World Outcomes. 2026;
    https://doi.org/10.1007/s40801-025-00530-w
  • Dijkstra L, Schink T, Linder R, Schwaninger M, Pigeot I, Wright MN, Foraita R. A discovery and verification approach to pharmacovigilance using electronic healthcare data. Frontiers in Pharmacology. 2024;15:1426323.
    https://doi.org/10.3389/fphar.2024.1426323
  • Wittström F, Cesta CE, Bateman BT, Bendix M, Bliddal M, Chan AYL, Cho Y, Choi E-Y, Cohen JM, Donald S, Gissler M, Havard A, Hernandez-Diaz S, Huybrechts KF, Kollhorst B, Leinonen MK, Li BMH, Man KKC, Ng VWS, Parkin L, Pazzagli L, Rasmussen L, Rotem RS, Schink T, Shin J-Y, Tran DT, Wong ICK, Zoega H, Reutfors J. Lithium use during pregnancy in 14 countries. JAMA Network Open. 2024;7(12):e2451117.
    https://doi.org/10.1001/jamanetworkopen.2024.51117
  • Haug U, Kollhorst B, Schink T, Thöne K, Dathe K, Schaefer C, Onken M. Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof-of-concept analysis on the association between valproate and spina bifida. Pharmacoepidemiology and Drug Safety. 2023;32(2):148-157.
    https://doi.org/10.1002/pds.5573
  • Asendorf M, Reinold J, Schink T, Kollhorst B, Haug U. Abbildbarkeit des sozioökonomischen Status in der pharmakoepidemiologischen Forschungsdatenbank GePaRD: Beschreibung und Anwendung am Beispiel des Zusammenhangs mit Adipositas. GMS Medizinische Informatik, Biometrie und Epidemiologie. 2022;18(1):Doc02.
    https://doi.org/10.3205/mibe000235
  • Platzbecker K, Voss A, Reinold J, Elbrecht A, Biewener W, Prieto-Alhambra D, Jödicke A, Schink T. Validation of algorithms to identify acute myocardial infarction, stroke, and cardiovascular death in German health insurance data. Clinical Epidemiology. 2022;14:1351-1361.
    https://doi.org/10.2147/CLEP.S380314
  • Thurin N, Pajouheshnia R, Roberto G, Dodd C, Hyeraci G, Bartolini C, Paoletti O, Nordeng H, Wallach-Kidemoes H, Ehrenstein V, Dudukina E, MacDonald T, De Paoli G, Loane M, Damase Michel C, Beau A-B, Droz-Perroteau C, Lassalle R, Bergmann J, Swart K, Schink T, Cavero-Carbonell C, Barrachina-Bonet L, Gomez-Lumbreras A, Giner-Soriano M, Aragon M, Neville A, Puccini A, Pierini A, Ientile V, Trifirò G, Rissmann A, Leinonen M, Martikainen V, Jordan S, Thayer D, Scanlon I, Georgiou M, Cunnington M, Swertz M, Sturkenboom MCJM, Gini R. From inception to ConcePTION: Genesis of a network to support better monitoring and communication of medication safety during pregnancy and breastfeeding. Clinical Pharmacology and Therapeutics. 2022;111(1):321-331.
    https://doi.org/10.1002/cpt.2476
  • Schäfer W, Wentzell N, Schink T, Haug U. Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis. Reproductive Toxicology. 2021;102:90-97.
    https://doi.org/10.1016/j.reprotox.2021.04.005
    https://repository.publisso.de/resource/frl%3A6428346
  • Gini R, Sturkenboom MCJM, Sultana J, Cave A, Landi A, Pacurariu A, Roberto G, Schink T, Candore G, Slattery J, Trifirò G, on behalf of the Working Group 3 of ENCePP. Different strategies to execute multi-database studies for medicines surveillance in real-world setting: A reflection on the European model. Clinical Pharmacology and Therapeutics. 2020;108(2):228-235.
    https://doi.org/10.1002/cpt.1833
  • Reutfors J, Cesta CE, Cohen JM, Bateman BT, Brauer R, Einarsdóttir K, Engeland A, Furu K, Gissler M, Havard A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Leinonen MK, Li J, Man KKC, Pazzagli L, Schaffer A, Schink T, Wang Z, Yu Y, Zoega H, Bröms G. Antipsychotic drug use in pregnancy: A multinational study from ten countries. Schizophrenia Research. 2020;220:106-115.
    https://doi.org/10.1016/j.schres.2020.03.048
  • Schink T, Wentzell N, Dathe K, Onken M, Haug U. Estimating the beginning of pregnancy in German claims data: Development of an algorithm with a focus on the expected delivery date. Frontiers in Public Health. 2020;8:350.
    https://doi.org/10.3389/fpubh.2020.00350
  • Wentzell N, Haug U, Schink T, Engel S, Liebentraut J, Linder R, Onken M, Schaefer C, Dathe K. Valproatverordnungen bei Mädchen und Frauen im gebärfähigen Alter in Deutschland: Untersuchung zeitlicher Trends basierend auf Versichertendaten. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2018;61(8):1022-1029.
    https://doi.org/10.1007/s00103-018-2768-1
  • Wentzell N, Schink T, Haug U, Ulrich S, Niemeyer M, Mikolajczyk R. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data. Pharmacoepidemiology and Drug Safety. 2018;27(9):1005-1010.
    https://doi.org/10.1002/pds.4588
    https://repository.publisso.de/resource/frl%3A6417552
  • Articles without peer review

  • Schink T, Princk C, Haug U. Risiko venöser Thromboembolien bei Einnahme von kombinierten hormonalen Kontrazeptiva. Bulletin zur Arzneimittelsicherheit - Informationen aus BfArM und PEI. 2021;2:13-16.
    https://www.bfarm.de/DE/Aktuelles/Publikationen/Bulletin/Ausgaben/_node.html
  • Books

  • Sturkenboom MCJM, Schink T, editors. Databases for pharmacoepidemiological research. Cham: Springer. 2021.
    https://doi.org/10.1007/978-3-030-51455-6
  • Book chapters

  • Enders D, Schink T, Stürmer T. Medicaid and Medicare. Cham. 2021.
    https://doi.org/10.1007/978-3-030-51455-6_19
    https://repository.publisso.de/resource/frl:6429818
  • Haug U, Schink T. German Pharmacoepidemiological Research Database (GePaRD). Cham. 2021.
    https://doi.org/10.1007/978-3-030-51455-6_8
    https://repository.publisso.de/resource/frl:6429817
  • Presentations at scientific meetings/conferences

  • Schink T, Kollhorst B, Haug U. Emulating a target trial to estimate the causal effect of antiseizure medication on birthweight. Berlin. 2024.
  • Presentations at scientific meetings/conferences (invited)

  • Schink T. Use of insurance data to study drug utilization in children with congenital malformations. online presentation. 2022.
  • Schink T. Establishment of a framework to study the utilization and safety of drugs during pregnancy in the German Pharmacoepidemiology Research Database (GePaRD). online presentation. 2021.

For further publications please follow this link:

  • Master of Science in Epidemiology, Johannes Gutenberg-Universiät, Mainz Pharmakoepidemiology, since 2013
  • Master of Science in Epidemiology, Ludwig-Maximilians-Universität, Munich Pharmakoepidemiology, since 2016

The responsibility for the content of this page lies with Tania Schink.

Tania Schink

Contact

Phone:
+49 (0)421 218-56-865